Fighting Diseases

Engineering T Cells to Prevent Type 1 Diabetes Takes Next Step Towards Human Clinical Trial

BRI and SCRI are making strides towards generating an engineered T cell product.
News & Views

BRI's Vision of Immune Health

A message from BRI President Jane Buckner, MD, about BRI's new, broader vision for immune health.
Fighting Diseases
Improving Diabetes Research Worldwide

Improving Diabetes Research Worldwide

Here are three ways we're using our expertise to improve type 1 diabetes research worldwide.
Fighting Diseases
Group of male scientists in laboratory

Pinpointing the Connection Between Cancer and Autoimmune Disease

Scientists at BRI are exploring the links between cancer and autoimmunity–and BRI is building an infrastructure to help them make progress against both types of disease.
Fighting Diseases
About 25 percent of people with autoimmune diseases have a tendency to develop additional autoimmune diseases.

Mystery Of Multiple Autoimmune Diseases

About 25 percent of people with autoimmune diseases have a tendency to develop additional autoimmune diseases.
Fighting Diseases
Discovering New Pathways for Treatment in Lupus - Dr. Jane Buckner and Dr. Jeff Carlin

Turning the Tide in Lupus Research

Discovering New Pathways for Treatment in Lupus
Fighting Diseases
Developing an Immunotherapy Cure for Type 1 Diabetes

Immunotherapy to Cure Type 1 Diabetes

Researchers at BRI and Seattle Children’s Research Institute are making key progress in their quest for an immunotherapy that cures type 1 diabetes once and for all.
Living With A Disease
We’re grateful to the Kleyn family for their autoimmune research participation,”

Three Sisters Honor Their Mother

Three sisters, Jeanne, Marilyn and Carol Kleyn, all joined the early research project SERA and the follow-up TIP-RA study.
Fighting Diseases

Exciting Breakthroughs in Preventing Rheumatoid Arthritis

What does it mean when scientists say they want to “prevent” a disease?